Chemotherapy for lung cancer in Spain: Our Best Clinics and Costs 2025

Professor Felip is in charge of thoracic malignancy management, and is responsible for thoracic cancer trials undertaken by the Oncology Department. Current research lines include the optimization of chemotherapy in early-stage disease, evaluation of new agents and therapies, research into novel pharmacogenomic approaches, the integration of immunotherapeutic approaches in the treatment of lung cancer patients, and the elucidation of potential mechanisms of resistance to tyrosine-kinase inhibitors. Formation Medical degree from the UAB, where she also completed her PhD studies in medical oncology.   Track Current member of the Spanish Lung Cancer Group (SLCG) and the Spanish Society of Medical Oncology (SEOM).   Member of the scientific committee of the SLCG.   SEOM Vice-President for the following years 2019-2021.   Member of the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), and the International Association for the Study of Lung Cancer (IASLC).   Member of the Board of Directors of IASLC (2017-2021). Co-chair of the 20th WCLC Congress that took place last September 2019 in Barcelona.   Dr. Felip receives the 1st ESMO Women for Oncology Award in 2015. President of the Oncology Comission at Vall d’Hebron University Hospital. Member of the Scientific Advisory Committee of the Parc Taulí Sabadell Hospital.   Publications Author of many peer-reviewed articles and book chapters relating to the field of thoracic malignancies.   Teaching Associate Professor at the Autonomous University of Barcelona (UAB) from 2010 to May 2019. Professor of Medicine at the Universitat de Vic (UVicc-UCC). She is involved in the training of medical students, residents and particularly in mentoring fellows.

Dr. Verges graduated in Medicine and Surgery from the University of Barcelona in 1980 and moved to Boston (USA) to conduct basic research in ophthalmology, obtaining a PhD in Biology from Harvard University and defending his doctoral thesis on the mechanisms of tear secretion, which would become the basis for understanding the pathology of dry eye syndrome (thesis presented in Barcelona, ​​1983) and which earned him the National Research Prize (1983). Currently, Dr. Carlos Verges carries out his professional activity as the Director of the Ophthalmology Service of the Dexéus University Hospital, together with his entire medical team from the advanced ophthalmology department, where he has a high-quality technological, medical and surgical team. His area of ​​interest is focused on the field of cataract and neurophysiological mechanisms of vision, especially in relation to sports. Professional experience 1983-1986 Associate Professor, Department of Ophthalmology, Faculty of Medicine, University of Barcelona, ​​Spain 1986-1989 Head of the Anterior Segment Unit, Department of Ophthalmology, Barcelona Hospital Clinic, Spain. 1986-1991 Professor of Ophthalmology, Faculty of Medicine, University of Barcelona, ​​Spain. 1990-1992 Head of Ophthalmology Service, Hospital del Mar, Barcelona. 1989-1999 Head of the Ophthalmology Department, Sagrada Familia Clinic, Barcelona, ​​Spain. From 2000 to present, President and CEO of the Dr. Carlos Verges Private Foundation. 2000-2007 Head of the Ophthalmology Department, Institut Universitari Dexeus, Barcelona, ​​Spain. 2007 – present General Director of the “Advanced Ophthalmology Department Dr. Verges”, Barcelona, ​​Spain. 2018-present President and Head of the Department of Ophthalmology. University Hospital Dexeus Quironsalud. Polytechnic University of Catalonia. Awards : - National Research Prize 1984. Ministry of Education and Science: "The mechanism of tear secretion. The importance of beta-adrenergic receptors in the lacrimation of the lacrimal glands." - National Prize for the best doctoral dissertation, Shibre Medal, 1984 "Personal contribution to the study of labial secretion. Determination of beta-adrenergic receptors in tear cells" - National Pharmaceutical Industry Award 1987: "Treatment of immunological rejection in corneal transplantation using cyclosporine A." - American Society of Implant Refractive Surgery (ASCRS) Award for the best scientific video presented at the annual conference: "Pseudo-Real Housing". First Prize. Seattle, USA, April 1999. - Award for the most important technical innovation of 1999 from the Spanish Society. Implantation-refractive surgery. Speaking at the National Congress held in Madrid 1999. - 2000 Best Scientific Contribution Award "Laser Non-Penetrating Deep Sclerectomy" presented at the American Academy of Ophthalmology Meeting, AAO - Dallas, USA, October 2000. - Best Paper Award for “GDx Analysis of Retinal Nerve Fiber Layer Thickness after LASIK” presented at the American Society of Cataract and Refractive Surgery, ASCRS, May 2004, San Diego, USA. - Finalist for the King Jaume I Prize for Basic Research, 2005, sponsored by the Board of Trustees of the Generalitat of Valencia and the Valencian Foundation for Advanced Research. - Surgical Technical Video Award: "MICS under Vision ICL, The Hook Technique" Presented at the IX International Congress of Cataract and Refractive Surgery, May/June 2006, Belo Horizonte, Brazil. Membership in scientific societies Member of the Executive Board of the International Society of Refractive Surgery (ISRS) and the American Academy of Ophthalmology (AAO). Member of the editorial board of Ophthalmology Times. Europe. Member of the editorial board of Cataract and Refractive Surgery (USA). Member of the Editorial Board of Cataract and Refractive Surgery Today Europe. Member of the European Society of Cataract and Refractive Surgery (ESCRS). Scientific reviewer of the journal: Cornea, Journal of Cataract and Refractive Surgery, American Academy of Ophthalmology, Cataract and Refractive Surgery and Archives of the Spanish Society of Ophthalmology.